Skip to main content
[Preprint]. 2023 Aug 21:rs.3.rs-3267009. [Version 1] doi: 10.21203/rs.3.rs-3267009/v1

Figure 2.

Figure 2

A) Representative staining of primary and recurrent tumors for CD3, CD8, and PDL1. B) Distribution of immune infiltration and PDL1 positive cells across primary and recurrent tumors.